Cyclacel Pharmaceuticals, Inc. 4
4 · Cyclacel Pharmaceuticals, Inc. · Filed Dec 10, 2013
Insider Transaction Report
Form 4
Rombotis Spiro George
DirectorPresident & C.E.O.
Transactions
- Award
Option
2013-12-09+105,000→ 105,000 totalExercise: $4.61Exp: 2023-12-09→ Common Stock (105,000 underlying)
Footnotes (2)
- [F1]These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
- [F2]These securities were issued as part of the Issuer's annual equity compensation to executive officers.